Second, the surface-decorated anti-CD47 molecules on B-LNP block the anti-phagocytic signal overexpressed in GBM cells and thus overcomes the barrier that GBM uses to escape myeloid clearance. This evidence concerns the gene CD47 and glioblastoma.